IGF2BP2 and cancer: In LSCC, stability of PLAU is regulated by a m6A methyltransferase WTAP resulting in cancer progression.20 As same as IGF2BP2, PLAU can also promotes cell proliferation and EMT in HNSCC that PLAU silencing inhibits the migration of OSCC Stage 4.